Latest Breaking News On - Ala lrmr us5171251003 - Page 1 : comparemela.com

BALA CYNWYD, Pa. — BALA CYNWYD, Pa. — Larimar Therapeutics, Inc. on Monday reported a loss of $6.5 million in its first quarter. On a per-share basis, the Bala Cynwyd,. | May 15, 2023

Bala cynwydUnited statesLarimar therapeutics incZacks investment researchAutomated insightsLarimar therapeuticsNc stock exchangePress releaseAla lrmr us5171251003